These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24097172)

  • 21. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C; Omizo M; Schwartz EN; Eriksen EF; Cantor P; Wang J; Glass EV; Myers SL; Krege JH
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
    Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
    Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of bone biochemical markers with dual-energy x-ray absorptiometry for early determination of bone loss in persons with spinal cord injury.
    Maïmoun L; Couret I; Micallef JP; Peruchon E; Mariano-Goulart D; Rossi M; Leroux JL; Ohanna F
    Metabolism; 2002 Aug; 51(8):958-63. PubMed ID: 12145766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mass and hormone analysis in patients with spinal cord injury: evidence for a gonadal axis disruption.
    Gaspar AP; Brandão CM; Lazaretti-Castro M
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4649-55. PubMed ID: 25222754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.
    Zibellini J; Seimon RV; Lee CM; Gibson AA; Hsu MS; Shapses SA; Nguyen TV; Sainsbury A
    J Bone Miner Res; 2015 Dec; 30(12):2168-78. PubMed ID: 26012544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
    Michalska D; Luchavova M; Zikan V; Raska I; Kubena AA; Stepan JJ
    Osteoporos Int; 2012 Dec; 23(12):2885-91. PubMed ID: 22426952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trabecular Bone Score at the Distal Femur and Proximal Tibia in Individuals With Spinal Cord Injury.
    Lobos S; Cooke A; Simonett G; Ho C; Boyd SK; Edwards WB
    J Clin Densitom; 2019; 22(2):249-256. PubMed ID: 29776736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
    Välimäki MJ; Salmela PI; Salmi J; Viikari J; Kataja M; Turunen H; Soppi E
    Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in bone mass and bone turnover following tibial shaft fracture.
    Veitch SW; Findlay SC; Hamer AJ; Blumsohn A; Eastell R; Ingle BM
    Osteoporos Int; 2006; 17(3):364-72. PubMed ID: 16362144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
    Oleson CV; Marino RJ; Formal CS; Modlesky CM; Leiby BE
    Spinal Cord; 2020 Aug; 58(8):921-929. PubMed ID: 32055041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.
    Alonso S; Ferrero E; Donat M; Martínez G; Vargas C; Hidalgo M; Moreno E
    J Endocrinol Invest; 2012 Jul; 35(7):640-4. PubMed ID: 21946027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of basic bone turnover parameters in short-term and long-term patients with spinal cord injury.
    Reiter AL; Volk A; Vollmar J; Fromm B; Gerner HJ
    Eur Spine J; 2007 Jun; 16(6):771-6. PubMed ID: 16830131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between spine osteoarthritis, bone mineral density and bone turn over markers in post menopausal women.
    Ichchou L; Allali F; Rostom S; Bennani L; Hmamouchi I; Abourazzak FZ; Khazzani H; El Mansouri L; Abouqal R; Hajjaj-Hassouni N
    BMC Womens Health; 2010 Aug; 10():25. PubMed ID: 20691114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis.
    Deng J; Feng Z; Li Y; Pan T; Li Q; Zhao C
    Medicine (Baltimore); 2018 Nov; 97(47):e13341. PubMed ID: 30461654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.
    Saag KG; Zanchetta JR; Devogelaer JP; Adler RA; Eastell R; See K; Krege JH; Krohn K; Warner MR
    Arthritis Rheum; 2009 Nov; 60(11):3346-55. PubMed ID: 19877063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
    Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN
    Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.